绦虫感染

White AC Jr, Coyle CM, Rajshekhar V, et al. Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2018 Apr 3;66(8):e49-75.全文  摘要

World Health Organization. ​WHO guidelines on management of Taenia solium neurocysticercosis. Sep 2021 [internet publication].全文

Del Brutto OH, Nash TE, White AC Jr, et al. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci. 2017 Jan 15;372:202-10.全文  摘要

Centers for Disease Control and Prevention. Parasites - taeniasis: resources for health professionals. Oct 2020 [internet publication].全文

1. Schantz PM, Kern P, Brunetti R. Echinococcus. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens and practice. 1st ed. Oxford, UK: Churchill Livingstone; 2005:1304-26.

2. Wittner M, Tanowitz HB, White AC. Taenia and other tapeworms. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens and practice. 1st ed. Oxford, UK: Churchill Livingstone; 2005:1327-40.

3. Hernández-Orts JS, Scholz T, Brabec J, et al. High morphological plasticity and global geographical distribution of the Pacific broad tapeworm Adenocephalus pacificus (syn. Diphyllobothrium pacificum): molecular and morphological survey. Acta Trop. 2015 Sep;149:168-78. 摘要

4. Garcia HH, del Brutto OH. Taenia solium cysticercosis. Inf Dis Clin North Am. 2000 Mar;14(1):97-119. 摘要

5. Verastegui M, Gilman RH, Garcia HH, et al. Prevalence of antibodies to unique Taenia solium onchosphere antigens in Taeniasis and human and porcine cysticercosis. Am J Trop Med Hyg. 2003 Oct;69(4):438-44.全文  摘要

6. Gonzalez AE, Garcia HH, Gilman RH, et al. Control of Taenia solium. Acta Trop. 2003 Jun;87(1):103-9. 摘要

7. Zoli A, Shey-Njila O, Assana E, et al. Regional status, epidemiology and impact of Taenia solium cysticercosis in Western and Central Africa. Acta Trop. 2003 Jun;87(1):35-42. 摘要

8. Braae UC, Thomas LF, Robertson LJ, et al. Epidemiology of Taenia saginata taeniosis/cysticercosis: a systematic review of the distribution in the Americas. Parasit Vectors. 2018 Sep 20;11(1):518.全文  摘要

9. O'Neal SE, Flecker RH. Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012. Emerg Infect Dis. 2015 Jun;21(6):969-76.全文  摘要

10. World Health Organization. Taeniasis/cysticercosis: fact sheet. Jan 2022 [internet publication].全文

11. Laranjo-González M, Devleesschauwer B, Trevisan C, et al. Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: Western Europe. Parasit Vectors. 2017 Jul 21;10(1):349.全文  摘要

12. Scholz T, Garcia HH, Kuchta R, et al. Update on the human broad tapeworm (genus diphyllobothrium), including clinical relevance. Clin Microbiol Rev. 2009 Jan;22(1):146-60.全文  摘要

13. Khalil HM, el Shimi S, Sarwat MA, et al. Recent study of Hymenolepis nana infection in Egyptian children. J Egypt Soc Parasitol. 1991 Apr;21(1):293-300. 摘要

14. Aria HP. Biology of the tapeworm Hymenolepis diminuta. New York, NY: Academic Press; 1980.

15. Biswas H, Arora RR, Sehgal S. Epidemiology of Hymenolepis nana infections in a selected rural community. J Commun Dis. 1978;10(3):170-4.

16. Mason PR, Patterson BA. Epidemiology of Hymenolepis nana infections in primary school children in urban and rural communities in Zimbabwe. J Parasitol. 1994 Apr;80(2):245-50. 摘要

17. World Health Organization. Echinococcosis: fact sheet​. May 2021 [internet publication].全文

18. Del Brutto OH, Sotelo J, Roman GC. Neurocysticercosis: a clinical handbook. Lisse, The Netherlands: Swets and Zeitlinger; 1998.

19. Bandres JC, White AC Jr, Samo T, et al. Extraparenchymal neurocysticercosis: report of five cases and review of management. Clin Infect Dis. 1992 Nov;15(5):799-811. 摘要

20. Garcia HH, Wittner M, Coyle CM, et al. Cysticercosis. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens and practice. 1st ed. Oxford, UK: Churchill Livingstone; 2005:1289-303.

21. Elmonir W, Elaadli H, Amer A, et al. Prevalence of intestinal parasitic infections and their associated risk factors among preschool and school children in Egypt. PLoS One. 2021;16(9):e0258037.全文  摘要

22. Gelaw A, Anagaw B, Nigussie B, et al. Prevalence of intestinal parasitic infections and risk factors among schoolchildren at the University of Gondar Community School, Northwest Ethiopia: a cross-sectional study. BMC Public Health. 2013 Apr 5;13:304.全文  摘要

23. Openshaw JJ, Medina A, Felt SA, et al. Prevalence and risk factors for Taenia solium cysticercosis in school-aged children: a school based study in western Sichuan, People's Republic of China. PLoS Negl Trop Dis. 2018 May;12(5):e0006465.全文  摘要

24. Pan American Health Organization. Guideline for preventive chemotherapy for the control of Taenia solium taeniasis. S​ep 2021 [internet publication].全文

25. Garcia HH, Gonzalez AE, Tsang VC, et al. Elimination of Taenia solium transmission in northern Peru. N Engl J Med. 2016 Jun 16;374(24):2335-44.全文  摘要

26. World Health Organization. Early detection and management of neurological serious adverse events in relation to the administration of anthelminthic medicines to people with asymptomatic neurocysticercosis. Sep 2023 [internet publication].全文

27. Di Lernia V, Ricci C, Albertini G. Skin eruption associated with Hymenolepis nana infection. Int J Dermatol. 2004 May;43(5):357-9. 摘要

28. Muehlenbachs A, Bhatnagar J, Agudelo CA, et al. Malignant transformation of Hymenolepis nana in a human host. N Engl J Med. 2015 Nov 5;373(19):1845-52.全文  摘要

29. Conn DB. Malignant transformation of Hymenolepis nana in a human host. N Engl J Med. 2016 Mar 31;374(13):1293-4. 摘要

30. Saeedan MB, Aljohani IM, Alghofaily KA, et al. Thoracic hydatid disease: a radiologic review of unusual cases. World J Clin Cases. 2020 Apr 6;8(7):1203-12.全文  摘要

31. Cuetter AC, Garcia-Bobadilla J, Guerra LG, et al. Neurocysticercosis: focus on intraventricular disease. Clin Infect Dis. 1997 Feb;24(2):157-64. 摘要

32. Department of Health, Victoria State Government, Australia. Taeniasis (tapeworm)​. Oct 2015 [internet publication].全文

33. White AC Jr, Coyle CM, Rajshekhar V, et al. Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2018 Apr 3;66(8):e49-75.全文  摘要

34. Centers for Disease Control and Prevention. CDC Yellow Book section 5: travel-associated infections & diseases - parasitic. Taeniasis. May 2023 [internet publication].全文

35. Proaño-Navarez JV, Meza-Lucas A, Mata-Ruiz O, et al. Laboratory diagnosis of human neurocysticercosis: double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay. J Clin Microbiol Rev. 2002 Jun;40(6):2115-8.全文  摘要

36. Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol. 2012 Apr;49(2):149-59.全文  摘要

37. Groove D. A history of human helminthology. Wallingford, UK: CAB International; 1990.

38. WHO Informal Working Group. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop. 2003 Feb;85(2):253-61. 摘要

39. World Health Organization. ​WHO guidelines on management of Taenia solium neurocysticercosis. Sep 2021 [internet publication].全文

40. Webb CM, White AC Jr. Update on the diagnosis and management of neurocysticercosis. Curr Infect Dis Rep. 2016 Dec;18(12):44. 摘要

41. Garcia HH, Gilman R, Martinez M, et al. Cysticercosis as a major cause of epilepsy in Peru. Lancet. 1993 Jan 23;341(8839):197-200. 摘要

42. Del Brutto OH, Nash TE, White AC Jr, et al. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci. 2017 Jan 15;372:202-10.全文  摘要

43. Carpio A, Fleury A, Romo ML, et al. New diagnostic criteria for neurocysticercosis: reliability and validity. Ann Neurol. 2016 Sep;80(3):434-42.全文  摘要

44. White AC Jr, Garcia HH. Updates on the management of neurocysticercosis. Curr Opin Infect Dis. 2018 Oct;31(5):377-82. 摘要

45. Centers for Disease Control and Prevention. Parasites - taeniasis: resources for health professionals. Oct 2020 [internet publication].全文

46. Centers for Disease Control and Prevention. Parasites - cysticercosis: resources for health professionals. Oct 2020 [internet publication].全文

47. Proaňo JV, Madrazo I, Avelar F, et al. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med. 2001 Sep 20;345(12):879-85.全文  摘要

48. Mitre E, Talaat KR, Sperling MR, et al. Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis. Clin Infect Dis. 2007 Feb 15;44(4):549-53. 摘要

49. Garcia HH, Lescano AG, Gonzales I, et al. Cysticidal efficacy of combined treatment with praziquantel and albendazole for parenchymal brain cysticercosis. Clin Infect Dis. 2016 Jun 1;62(11):1375-9. 摘要

50. Garcia HH, Gonzales I, Lescano AG, et al. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis. 2014 Aug;14(8):687-95. 摘要

51. Monk E, Abba K, Ranganathan L. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD000215.全文  摘要

52. Walton D, Castell H, Collie C, et al. Antiepileptic drugs for seizure control in people with neurocysticercosis. Cochrane Database Syst Rev. 2021 Nov 1;11(11):CD009027.全文  摘要

53. Garcia HH, Gonzales I, Lescano AG, et al. Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after. Epilepsia. 2014 Sep;55(9):1452-9.全文  摘要

54. Koul PA, Singh AA, Ahanger AG, et al. Optimal duration of preoperative anti-helminthic therapy for pulmonary hydatid surgery. ANZ J Surg. 2010 May;80(5):354-7. 摘要

55. Khuroo MS, Wani NA, Javid G, et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med. 1997 Sep 25;337(13):881-7.全文  摘要

56. Smego RA Jr, Bhatti S, Khaliq AA, et al. Percutaneous aspiration-injection-reaspiration drainage plus albendazole or mebendazole for hepatic cystic echinococcosis: a meta-analysis. Clin Infect Dis. 2003 Oct 15;37(8):1073-83. 摘要

57. The Medical Letter. Drugs for parasitic infections. New Rochelle, NY: The Medical Letter; 2007.

58. An G, Murry DJ, Gajurel K, et al. Pharmacokinetics, safety, and tolerability of oxfendazole in healthy volunteers: a randomized, placebo-controlled first-in-human single-dose escalation study. Antimicrob Agents Chemother. 2019 Apr;63(4):e02255-18.全文  摘要

59. Bach T, Galbiati S, Kennedy JK, et al. Pharmacokinetics, safety, and tolerability of oxfendazole in healthy adults in an open-label phase 1 multiple ascending dose and food effect study. Antimicrob Agents Chemother. 2020 Oct 20;64(11):e01018-20.全文  摘要